ADMA ADMA Biologics Inc

4.35
+0.37  (+9%)
Previous Close 3.98
Open 4
Price To Book 5.44
Market Cap 201627907
Shares 46,351,243
Volume 331,565
Short Ratio
Av. Daily Volume 504,803

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL issued July 29 2016. New PDUFA date April 2, 2019.
RI-002
Primary Immune Deficiency Diseases
Response to Complete Response Letter submitted January 7, 2019.
BIVIGAM
Primary humoral immunodeficiency

SEC Filings

  1. SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 19607066
  2. SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 19600761
  3. SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 19597520
  4. 8-K - Current report 19587661
  5. 8-K - Current report 19549523
  6. 8-K - Current report 19512162
  7. 8-K - Current report 19502416
  8. 8-K - Current report 181246649
  9. 8-K - Current report 181244295
  10. 8-K - Current report 181242815